Application of mathematical model of immunological tolerance to HIV infection. NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Application of mathematical model of immunological tolerance to HIV infection.

Folia Biol (Praha). 1988;34(5):336-41. Unique Identifier : AIDSLINE MED/89211510
Dolezal J; Hraba T; Institute of Information Theory and Automation, Czechoslovak; Academy of Sciences, Praha.

Abstract: Our experimental model of immunological tolerance to non-reproducing antigens is based on the assumption that tolerance is caused by elimination or irreversible inactivation of lymphocytes reacting specifically with the tolerance inducing antigen, and that recovery from tolerance is due to the spontaneous maturation from the stem cells of new lymphocytes reacting with the tolerated antigen. The recovery starts, when the antigen is eliminated from the organism and does not induce tolerance in newly arising lymphocytes any more. Here we report the application of this model to the depletion of CD4+ lymphocytes in persons infected with HIV. This depletion seems to be effected either directly or indirectly by HIV products. Therefore, the dynamics of this depletion can be described by the equations characterizing the dynamics of lymphocytes exposed to tolerance inducing antigen, when HIV products are substituted for antigen. In contrast to non-replicating antigens, the concentration of HIV products increases, as the infection progresses. In consequence, the CD4+ lymphocyte depletion increases with time and its dynamics are reciprocal to those of tolerance to non-reproducing antigens, which decrease with time.
Keywords: Acquired Immunodeficiency Syndrome/*IMMUNOLOGY Human *Immune Tolerance *Models, Biological JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDimmunologyhumanKWDimmunetoleranceKWDmodels,biologicaljournalarticle
890830
M8980797

Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .